91 results on '"Takaha N"'
Search Results
2. Inhibition of the nuclear factor-κB inducible interleukin-6 expression mediated through glucocorticoid receptor in androgen-independent prostate cancer
3. UP-01.045 Experience of Gemcitabine and Nedaplatin for Unfit Patients With Advanced Urothelial Cancer
4. UP-03.111 TIN Therapy as Salvage Chemotherapy for Cisplatin Refractory Germ Cell Tumors
5. Intra-arterial chemotherapy for local invasive bladder cancer.
6. The role of magnetic resonance imaging in targeting prostate cancer in patients with elevated prostate-specific antigen levels.
7. Feasibility of triweekly docetaxel-based chemotherapy for elderly patients (age 75 and older) with castration-resistant prostate cancer.
8. 392 CDK1 AND CDK2 ACTIVITY IS A STRONG PREDICTOR OF RENAL CELL CANCER RECURRENCE
9. Use of CDK1 and CDK2 activity to predict renal cell cancer recurrence.
10. Use of CDK1 and CDK2 activity to predict renal cell cancer recurrence.
11. UP-3.026: Bladder Preservation Therapy for the Treatment of Patients with Local Invasive Bladder Cancer
12. MP-05.01: Radio-Frequency Ablation (RFA) for Post-Chemotherapeutic Metastatic Germ Cell Tumors as Minimally Invasive Salvage Therapy
13. UP-2.127: Clinical Outcome of External Beam Radiation Therapy Combined with Neoadjuvant, Concurrent and Adjuvant Hormone Therapy for Japanese Patients with T3N0M0 Prostate Cancer
14. Salvage chemotherapy with irinotecan and nedaplatin for cisplatin refractory germ cell tumors
15. Significance of the expression of thymidylate synthase in prostate cancer
16. Prognostic outcome in Japanese men with prostate cancer treated with androgen-deprivation therapy (ADT) alone: Data from multi-institutional cooperative study in Kyoto Prostate Cancer Registry (KPCR)
17. Prognostic significance of x-linked inhibitor of apoptosis protein expression in renal cell carcinoma
18. MP-21.08: Salvage chemotherapy with paclitaxel, gemcitabine and nedaplatin (TGN) for cisplatin refractory germ cell tumors
19. Enhanced orotate phosphoribosyltransferase activity in renal cell carcinoma and its prognostic significance
20. Oral Combination of Cyclophosphamide, Uracil plus Tegafur and Estramustine for Hormone-Refractory Prostate Cancer
21. The expression of gicerin, a cell adhesion molecule, in regenerating process of collecting ducts and ureters of the chicken kidney following infection with a nephrotropic strain of infectious bronchitis virus
22. Purification and Characterization of Three MEKA-Like Proteins in Liver: Association of a 94 kDa Protein with β γ Subunits of G-Proteins
23. Low doses of oral dexamethasone for hormone-refractory prostate carcinoma.
24. Soluble Fas in serum from patients with renal cell carcinoma - a protein tyrosine phosphatase that associates with Fas
25. Expression and functional analysis of a novel isoform of gicerin, an immunoglobulin superfamily cell adhesion molecule.
26. Fricative inspection with wavelet analysis.
27. A0337 - Phase I/II study of multipeptide cancer vaccine IMA901 in Japanese patients with advanced renal cell cancer with long-term follow up.
28. Extracellular matrix proteins with neurite promoting activity and their receptors
29. Phase I/II study of multipeptide cancer vaccine IMA901 after single-dose cyclophosphamide in Japanese patients with advanced renal cell cancer with long-term follow up.
30. Preliminary study of the safety of acrinol in probe-based confocal laser endomicroscopy during transurethral resection of bladder tumors.
31. Randomized study of intravesical pirarubicin chemotherapy with low and intermediate-risk nonmuscle-invasive bladder cancer in Japan: Comparison of a single immediate postoperative intravesical instillation with short-term adjuvant intravesical instillations after transurethral resection.
32. Probe-Based Confocal Laser Endomicroscopy Using Acrinol as a Novel Dye Can Be Used to Observe Cancer Nuclei of Bladder Carcinoma In Situ .
33. CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence.
34. Significance of serum tumor necrosis factor-related apoptosis-inducing ligand as a prognostic biomarker for renal cell carcinoma.
35. Impact of four loci on serum tamsulosin hydrochloride concentration.
36. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.
37. High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells.
38. Expression and role of HMGA1 in renal cell carcinoma.
39. Significant induction of apoptosis in renal cell carcinoma cells transfected with cationic multilamellar liposomes containing the human interferon-β gene through activation of the intracellular type 1 interferon signal pathway.
40. Optimal duration of androgen deprivation in combination with radiation therapy for Japanese men with high-risk prostate cancer.
41. Feasibility of tri-weekly docetaxel-based chemotherapy for elderly patients (age 75 and older) with castration-resistant prostate cancer.
42. [Radio-frequency ablation (RFA) for post-chemotherapeutic metastatic germ cell tumors as minimally invasive salvage therapy].
43. Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors.
44. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
45. The significance of the expression of dihydropyrimidine dehydrogenase in prostate cancer.
46. [Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy: a case report].
47. Significance of electrostimulation in detecting neurovascular bundle during radical prostatectomy.
48. Prostate cancer mediates osteoclastogenesis through two different pathways.
49. [Adrenal ganglioneuroma: a case report].
50. [Castleman disease in the pelvic cavity].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.